ViiV Healthcare GmbH
ViiV Healthcare is a world-leading, independent specialist company that is 100% focused on researching, developing and delivering innovative medicines for the treatment and prevention of HIV and AIDS. Founded from an alliance of GSK, Pfizer and Shionogi, ViiV Healthcare has set itself the goal of combating and one day ending the HIV epidemic through continuous innovation since 2009. The company takes a holistic approach that takes into account both medical and social aspects[1][2][5].
The product portfolio of ViiV Healthcare currently comprises 17 prescription HIV medicines that are used worldwide. At the heart of the research is the world's only HIV-specialized research center in Branford, Connecticut, which is continuously working on the development of new therapies to further improve the quality of life of people with HIV and to make preventive measures such as PrEP (pre-exposure prophylaxis) more accessible[2][4].
The company's mission is clearly and unambiguously formulated: "No person living with HIV left behind" – no one should be left behind. This commitment is implemented through an inclusive, patient-centered approach that actively involves the voices of HIV-positive communities and works in partnership with them. ViiV Healthcare promotes a corporate culture characterized by integrity, accountability and an ambitious will to achieve impact quickly and purposefully[1][3][5].
In terms of sustainability and social commitment, ViiV Healthcare also invests in programs to support particularly affected populations on a global level. The company is committed to the accessibility of its medicines, regardless of income, origin, age or gender, thereby strengthening health and quality of life in disadvantaged communities. These initiatives are an integral part of the corporate strategy, which sees the fight against HIV as a multidimensional goal[1][3][5].
In summary, ViiV Healthcare is an internationally respected, specialized pharmaceutical company that shapes the future of HIV treatment with technological progress, global partnerships and a strong sense of social responsibility and is tirelessly committed to ending the HIV pandemic.
